SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 58.08+0.9%Dec 11 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (2306)12/15/2000 1:47:39 PM
From: tom pope  Read Replies (1) of 52153
 
It certainly seems that nobody wants to buy MAXM yet. Surprising that it continued to fall another 50% from the level it sank to after the FDA stat study was posted on the FDA site. I am assuming that the continued fall is due to the suggestion of deliberate manipulation of the data.
I unfortunately sold the Jan 20 puts at 9, thankfully only 2 contracts.
INCY is back at a level where a buy has proven to be profitable recently
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News